PDB Short entry for 4BKZ HEADER TRANSFERASE 30-APR-13 4BKZ TITLE CRYSTAL STRUCTURE OF UNPHOSPHORYLATED MATERNAL EMBRYONIC LEUCINE TITLE 2 ZIPPER KINASE (MELK) IN COMPLEX WITH A BENZODIPYRAZOLE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE AND UBA DOMAINS, RESIDUES 2-340; COMPND 5 SYNONYM: HMELK, PROTEIN KINASE EG3, PEG3 KINASE, PROTEIN KINASE PK38, COMPND 6 HPK38, TYROSINE-PROTEIN KINASE MELK; COMPND 7 EC: 2.7.11.1, 2.7.10.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR G.CANEVARI,S.RE DEPAOLINI,U.CUCCHI,B.FORTE,P.CARPINELLI,J.A.BERTRAND REVDAT 3 24-APR-19 4BKZ 1 SOURCE REVDAT 2 02-OCT-13 4BKZ 1 JRNL REVDAT 1 21-AUG-13 4BKZ 0 JRNL AUTH G.CANEVARI,S.RE DEPAOLINI,U.CUCCHI,J.A.BERTRAND,E.CASALE, JRNL AUTH 2 C.PERRERA,B.FORTE,P.CARPINELLI,E.R.FELDER JRNL TITL STRUCTURAL INSIGHT INTO MATERNAL EMBRYONIC LEUCINE ZIPPER JRNL TITL 2 KINASE (MELK) CONFORMATION AND INHIBITION TOWARDS STRUCTURE- JRNL TITL 3 BASED DRUG DESIGN. JRNL REF BIOCHEMISTRY V. 52 6380 2013 JRNL REFN ISSN 0006-2960 JRNL PMID 23914841 JRNL DOI 10.1021/BI4005864 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 52.64 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 3 NUMBER OF REFLECTIONS : 17811 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 966 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1315 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.36 REMARK 3 BIN R VALUE (WORKING SET) : 0.2770 REMARK 3 BIN FREE R VALUE SET COUNT : 75 REMARK 3 BIN FREE R VALUE : 0.3190 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2530 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 27 REMARK 3 SOLVENT ATOMS : 80 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.18 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.20000 REMARK 3 B22 (A**2) : -0.11000 REMARK 3 B33 (A**2) : 2.30000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.270 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.208 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.957 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.930 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2622 ; 0.010 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3545 ; 1.577 ; 1.983 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 306 ; 6.115 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 120 ;34.942 ;24.250 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 483 ;17.490 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 13 ;20.056 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 391 ; 0.086 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1938 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 4BKZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-APR-13. REMARK 100 THE DEPOSITION ID IS D_1290056700. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-APR-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9762 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18810 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 60.440 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.60 REMARK 200 R MERGE FOR SHELL (I) : 0.48000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1ZMU REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% PEG 3350, 0.1M BIS-TRIS PH 6.5, REMARK 280 0.2M SODIUM CHLORIDE REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 30.22000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.65500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.57500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 47.65500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 30.22000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 31.57500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 PRO A 1 REMARK 465 GLY A 21 REMARK 465 PHE A 22 REMARK 465 GLY A 48 REMARK 465 SER A 49 REMARK 465 ASP A 50 REMARK 465 LYS A 156 REMARK 465 PRO A 157 REMARK 465 LYS A 158 REMARK 465 GLY A 159 REMARK 465 ASN A 160 REMARK 465 LYS A 161 REMARK 465 ASP A 162 REMARK 465 TYR A 163 REMARK 465 HIS A 164 REMARK 465 LEU A 165 REMARK 465 GLN A 166 REMARK 465 THR A 167 REMARK 465 CYS A 168 REMARK 465 CYS A 169 REMARK 465 GLY A 170 REMARK 465 LYS A 183 REMARK 465 SER A 184 REMARK 465 TYR A 185 REMARK 465 LEU A 186 REMARK 465 SER A 335 REMARK 465 SER A 336 REMARK 465 PHE A 337 REMARK 465 SER A 338 REMARK 465 CYS A 339 REMARK 465 GLY A 340 REMARK 465 HIS A 341 REMARK 465 HIS A 342 REMARK 465 HIS A 343 REMARK 465 HIS A 344 REMARK 465 HIS A 345 REMARK 465 HIS A 346 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 114 NE - CZ - NH1 ANGL. DEV. = 3.0 DEGREES REMARK 500 ARG A 114 NE - CZ - NH2 ANGL. DEV. = -3.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 14 -154.62 -122.37 REMARK 500 THR A 46 48.16 -75.24 REMARK 500 ASP A 102 -60.97 75.77 REMARK 500 ARG A 131 -4.23 69.02 REMARK 500 ASP A 132 44.67 -141.15 REMARK 500 ASP A 150 76.56 61.20 REMARK 500 LEU A 244 49.43 -95.75 REMARK 500 ASP A 266 -12.27 74.32 REMARK 500 ASN A 277 63.45 63.23 REMARK 500 ARG A 295 50.46 39.31 REMARK 500 ASP A 311 -165.24 -104.15 REMARK 500 VAL A 330 86.45 -68.70 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1WS A 1335 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4BKY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF UNPHOSPHORYLATED MATERNAL EMBRYONIC LEUCINE REMARK 900 ZIPPER KINASE (MELK) IN COMPLEX WITH PYRROLOPYRAZOLE INHIBITOR REMARK 900 RELATED ID: 4BL1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF UNPHOSPHORYLATED MATERNAL EMBRYONIC LEUCINE REMARK 900 ZIPPER KINASE (MELK) IN COMPLEX WITH AMP-PNP DBREF 4BKZ A 2 340 UNP Q14680 MELK_HUMAN 2 340 SEQADV 4BKZ GLY A 0 UNP Q14680 EXPRESSION TAG SEQADV 4BKZ PRO A 1 UNP Q14680 EXPRESSION TAG SEQADV 4BKZ HIS A 341 UNP Q14680 EXPRESSION TAG SEQADV 4BKZ HIS A 342 UNP Q14680 EXPRESSION TAG SEQADV 4BKZ HIS A 343 UNP Q14680 EXPRESSION TAG SEQADV 4BKZ HIS A 344 UNP Q14680 EXPRESSION TAG SEQADV 4BKZ HIS A 345 UNP Q14680 EXPRESSION TAG SEQADV 4BKZ HIS A 346 UNP Q14680 EXPRESSION TAG SEQRES 1 A 347 GLY PRO LYS ASP TYR ASP GLU LEU LEU LYS TYR TYR GLU SEQRES 2 A 347 LEU HIS GLU THR ILE GLY THR GLY GLY PHE ALA LYS VAL SEQRES 3 A 347 LYS LEU ALA CYS HIS ILE LEU THR GLY GLU MET VAL ALA SEQRES 4 A 347 ILE LYS ILE MET ASP LYS ASN THR LEU GLY SER ASP LEU SEQRES 5 A 347 PRO ARG ILE LYS THR GLU ILE GLU ALA LEU LYS ASN LEU SEQRES 6 A 347 ARG HIS GLN HIS ILE CYS GLN LEU TYR HIS VAL LEU GLU SEQRES 7 A 347 THR ALA ASN LYS ILE PHE MET VAL LEU GLU TYR CYS PRO SEQRES 8 A 347 GLY GLY GLU LEU PHE ASP TYR ILE ILE SER GLN ASP ARG SEQRES 9 A 347 LEU SER GLU GLU GLU THR ARG VAL VAL PHE ARG GLN ILE SEQRES 10 A 347 VAL SER ALA VAL ALA TYR VAL HIS SER GLN GLY TYR ALA SEQRES 11 A 347 HIS ARG ASP LEU LYS PRO GLU ASN LEU LEU PHE ASP GLU SEQRES 12 A 347 TYR HIS LYS LEU LYS LEU ILE ASP PHE GLY LEU CYS ALA SEQRES 13 A 347 LYS PRO LYS GLY ASN LYS ASP TYR HIS LEU GLN THR CYS SEQRES 14 A 347 CYS GLY SER LEU ALA TYR ALA ALA PRO GLU LEU ILE GLN SEQRES 15 A 347 GLY LYS SER TYR LEU GLY SER GLU ALA ASP VAL TRP SER SEQRES 16 A 347 MET GLY ILE LEU LEU TYR VAL LEU MET CYS GLY PHE LEU SEQRES 17 A 347 PRO PHE ASP ASP ASP ASN VAL MET ALA LEU TYR LYS LYS SEQRES 18 A 347 ILE MET ARG GLY LYS TYR ASP VAL PRO LYS TRP LEU SER SEQRES 19 A 347 PRO SER SER ILE LEU LEU LEU GLN GLN MET LEU GLN VAL SEQRES 20 A 347 ASP PRO LYS LYS ARG ILE SER MET LYS ASN LEU LEU ASN SEQRES 21 A 347 HIS PRO TRP ILE MET GLN ASP TYR ASN TYR PRO VAL GLU SEQRES 22 A 347 TRP GLN SER LYS ASN PRO PHE ILE HIS LEU ASP ASP ASP SEQRES 23 A 347 CYS VAL THR GLU LEU SER VAL HIS HIS ARG ASN ASN ARG SEQRES 24 A 347 GLN THR MET GLU ASP LEU ILE SER LEU TRP GLN TYR ASP SEQRES 25 A 347 HIS LEU THR ALA THR TYR LEU LEU LEU LEU ALA LYS LYS SEQRES 26 A 347 ALA ARG GLY LYS PRO VAL ARG LEU ARG LEU SER SER PHE SEQRES 27 A 347 SER CYS GLY HIS HIS HIS HIS HIS HIS HET 1WS A1335 27 HETNAM 1WS N-(3-AMINOPROPYL)-8-[(3-FLUOROPHENYL)AMINO]-2,4,5,7- HETNAM 2 1WS TETRAHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE FORMUL 2 1WS C18 H20 F N7 O FORMUL 3 HOH *80(H2 O) HELIX 1 1 GLU A 6 TYR A 10 1 5 HELIX 2 2 LEU A 51 LEU A 64 1 14 HELIX 3 3 LEU A 94 ASP A 102 1 9 HELIX 4 4 SER A 105 GLN A 126 1 22 HELIX 5 5 LYS A 134 GLU A 136 5 3 HELIX 6 6 SER A 171 ALA A 175 5 5 HELIX 7 7 ALA A 176 GLN A 181 1 6 HELIX 8 8 GLY A 187 GLY A 205 1 19 HELIX 9 9 ASN A 213 GLY A 224 1 12 HELIX 10 10 SER A 233 LEU A 244 1 12 HELIX 11 11 ASP A 247 ARG A 251 5 5 HELIX 12 12 SER A 253 ASN A 259 1 7 HELIX 13 13 HIS A 260 GLN A 265 1 6 HELIX 14 14 ASP A 283 ARG A 295 1 13 HELIX 15 15 ASN A 297 SER A 306 1 10 HELIX 16 16 ASP A 311 ARG A 326 1 16 SHEET 1 AA 5 TYR A 11 GLY A 18 0 SHEET 2 AA 5 LYS A 24 HIS A 30 -1 O VAL A 25 N ILE A 17 SHEET 3 AA 5 MET A 36 ASP A 43 -1 O VAL A 37 N ALA A 28 SHEET 4 AA 5 LYS A 81 GLU A 87 -1 O ILE A 82 N MET A 42 SHEET 5 AA 5 LEU A 72 GLU A 77 -1 N TYR A 73 O VAL A 85 SHEET 1 AB 3 GLY A 92 GLU A 93 0 SHEET 2 AB 3 LEU A 138 PHE A 140 -1 N PHE A 140 O GLY A 92 SHEET 3 AB 3 LEU A 146 LEU A 148 -1 O LYS A 147 N LEU A 139 SITE 1 AC1 12 ILE A 17 ALA A 38 LYS A 40 GLU A 87 SITE 2 AC1 12 TYR A 88 CYS A 89 PRO A 90 ASN A 137 SITE 3 AC1 12 LEU A 139 ILE A 149 ASP A 150 HOH A2006 CRYST1 60.440 63.150 95.310 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016545 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015835 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010492 0.00000